- Home
- NFJ vs INMD Comparison
NFJ vs INMD Comparison
Compare NFJ & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFJ
- INMD
- Stock Information
- Founded
- NFJ 2005
- INMD 2008
- Country
- NFJ United States
- INMD Israel
- Employees
- NFJ N/A
- INMD N/A
- Industry
- NFJ Finance: Consumer Services
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NFJ Finance
- INMD Health Care
- Exchange
- NFJ Nasdaq
- INMD Nasdaq
- Market Cap
- NFJ 1.2B
- INMD 1.3B
- IPO Year
- NFJ N/A
- INMD 2019
- Fundamental
- Price
- NFJ $12.14
- INMD $17.74
- Analyst Decision
- NFJ
- INMD Buy
- Analyst Count
- NFJ 0
- INMD 5
- Target Price
- NFJ N/A
- INMD $22.25
- AVG Volume (30 Days)
- NFJ 223.5K
- INMD 1.2M
- Earning Date
- NFJ 01-01-0001
- INMD 05-01-2025
- Dividend Yield
- NFJ 9.01%
- INMD N/A
- EPS Growth
- NFJ N/A
- INMD N/A
- EPS
- NFJ N/A
- INMD 2.25
- Revenue
- NFJ N/A
- INMD $394,818,000.00
- Revenue This Year
- NFJ N/A
- INMD $1.92
- Revenue Next Year
- NFJ N/A
- INMD $5.31
- P/E Ratio
- NFJ N/A
- INMD $7.88
- Revenue Growth
- NFJ N/A
- INMD N/A
- 52 Week Low
- NFJ $10.45
- INMD $14.87
- 52 Week High
- NFJ $12.86
- INMD $21.76
- Technical
- Relative Strength Index (RSI)
- NFJ 40.29
- INMD 41.01
- Support Level
- NFJ $12.07
- INMD $18.11
- Resistance Level
- NFJ $12.26
- INMD $19.09
- Average True Range (ATR)
- NFJ 0.15
- INMD 0.67
- MACD
- NFJ 0.01
- INMD -0.12
- Stochastic Oscillator
- NFJ 50.34
- INMD 26.66
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. Its primary investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.